Kovo+ Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Kovo+ Holdings şirketinin toplam hissedar öz sermayesi $-3.2M ve toplam borcu $9.3M olup, bu da borç-öz sermaye oranını -290.9% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $8.9M ve $12.1M dir.

Anahtar bilgiler

-290.9%

Borç/özkaynak oranı

US$9.30m

Borç

Faiz karşılama oranı	n/a
Nakit	US$84.00k
Eşitlik	-US$3.20m
Toplam yükümlülükler	US$12.14m
Toplam varlıklar	US$8.94m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Market Might Still Lack Some Conviction On Kovo HealthTech Corporation (CVE:KOVO) Even After 50% Share Price Boost

Sep 20

Kovo HealthTech Corporation (CVE:KOVO) Stock's 33% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Aug 03

A Piece Of The Puzzle Missing From Kovo HealthTech Corporation's (CVE:KOVO) 40% Share Price Climb

Jun 19

Investors Give Kovo HealthTech Corporation (CVE:KOVO) Shares A 27% Hiding

May 02

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: KOVO negatif hissedar özkaynağı var; bu, kısa vadeli varlıkların kısa vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Uzun Vadeli Yükümlülükler: KOVO şirketinin negatif özkaynağı bulunmaktadır; bu, kısa vadeli varlıkların uzun vadeli yükümlülükleri karşılamamasından daha ciddi bir durumdur.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: KOVO negatif hissedar özkaynağı var ki bu yüksek borç seviyesinden daha ciddi bir durumdur.

Borcun Azaltılması: KOVO 'in negatif özkaynağı var, dolayısıyla borcunun zaman içinde azalıp azalmadığını kontrol etmemize gerek yok.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: KOVO şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: KOVO un, serbest nakit akışı her yıl % 33 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Kovo+ Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Kovo HealthTech Corporation, Annual General Meeting, Dec 16, 2024

Kovo HealthTech Corporation (TSXV:KOVO) completed the acquisition of certain contractual assets of Coredynamex, LLC.

Kovo HealthTech Corporation (TSXV:KOVO) signed a asset purchase agreement to acquire certain contractual assets of Coredynamex, LLC for $0.54 million.

Market Might Still Lack Some Conviction On Kovo HealthTech Corporation (CVE:KOVO) Even After 50% Share Price Boost

Second quarter 2024 earnings released: US$0.014 loss per share (vs US$0.024 loss in 2Q 2023)

Kovo HealthTech Corporation (CVE:KOVO) Stock's 33% Dive Might Signal An Opportunity But It Requires Some Scrutiny

New major risk - Shareholder dilution

Kovo HealthTech Corporation Announces CEO Changes

A Piece Of The Puzzle Missing From Kovo HealthTech Corporation's (CVE:KOVO) 40% Share Price Climb

First quarter 2024 earnings released: US$0.037 loss per share (vs US$0.021 loss in 1Q 2023)

Investors Give Kovo HealthTech Corporation (CVE:KOVO) Shares A 27% Hiding

Full year 2023 earnings released: US$0.09 loss per share (vs US$0.006 loss in FY 2022)

High number of new directors

High number of new and inexperienced directors

Third quarter 2023 earnings released: US$0.014 loss per share (vs US$0.006 profit in 3Q 2022)

High number of new and inexperienced directors

Kovo HealthTech Corporation, Annual General Meeting, Nov 17, 2023

Second quarter 2023 earnings released: US$0.024 loss per share (vs US$0.006 loss in 2Q 2022)

Kovo Healthtech Corporation Launches Advanced Platform, Kovocloud

Kovo HealthTech Corporation Appoints Eddie Chan as its Chief Technology Officer

Kovo HealthTech Corporation (TSXV:KOVO) entered into a binding agreement to acquire All Assets of Kairos Billing Solutions, LLC for $0.15 million.

First quarter 2023 earnings released: US$0.021 loss per share (vs US$0.009 loss in 1Q 2022)

High number of new and inexperienced directors

Full year 2022 earnings released: US$0.006 loss per share (vs US$0.083 loss in FY 2021)

Third quarter 2022 earnings released: EPS: US$0.006 (vs US$0.014 loss in 3Q 2021)

High number of new and inexperienced directors

Second quarter 2022 earnings released: US$0.006 loss per share (vs US$0.017 loss in 2Q 2021)

Kovo HealthTech Corporation Provides Earnings Guidance for the Full Year 2022

High number of new and inexperienced directors

High number of new and inexperienced directors

Kovo HealthTech Corporation, Annual General Meeting, Aug 17, 2022

Kovo HealthTech Corporation Announces Board of Directors Resignations

Kovo HealthTech Corporation Provides Revenue Guidance for the Year of 2022

Kovo HealthTech Corporation (TSXV:KOVO) completed the acquisition of Substantially all of the assets of The Cvikota Company, Inc.

Kovo HealthTech Corporation (TSXV:KOVO) entered into a binding letter of intent to acquire Substantially all of the assets of Midwest Medical Billing, Service Inc. for for $0.91 million.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin